You may get more information at Renal & Urology News website:
quarta-feira, 4 de dezembro de 2013
Tasquinimod, a possible new weapon against metastasized prostate cancer.
Still in an experimental study, a drug called tasquinimod promises to revolutionize the treatment of metastasized prostate cancer. It´s an oral immunomodulatory, antimetastatic and antiangiogenic (prevents the new blood vessels formation) drug, which has properties that slows prostate tumors progress in the castration resistant tumors.